Immuron Limited operates within the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Immuron Limited with three other
pharmaceutical manufacturers in Australasia:
Paradigm Biopharmaceuticals Ltd
sales of 1.39 million Australian Dollars [US$1.10 million]
(878,394.00 Australian Dollars [US$695,486.02 ]
(1.19 million Australian Dollars [US$939,998.85 ]
During the year ended June of 2016, sales at
Immuron Limited were A$1.16 million (US$914.91 thousand).
increase of 2.8%
versus 2015, when the company's sales were A$1.12 million.
This was the third consecutive year of growth at Immuron Limited.